Fondation Pierre Fabre

What Fondation Pierre Fabre does

Fondation Pierre Fabre is a French private non-profit foundation recognised as a public utility (reconnue d'utilité publique) since 1999 and headquartered in Lavaur, France, with a small staff of 11-50 employees. It funds and operates programmes that improve access to quality medicines, healthcare, and health education for vulnerable populations in the Global South, currently running 35 active programmes across 22 countries spanning sub-Saharan Africa, Southeast Asia, the Middle East, the Caribbean, and Eastern Europe. Its work is organised around five intervention pillars: training of pharmaceutical professionals (anchored by the transnational Master Mekong Pharma programme in Vietnam, Cambodia, and Laos), combating sickle cell disease, healthcare access for vulnerable populations including survivors of sexual violence, e-health (including the Global South E-Health Observatory ODESS and a diploma with four African universities), and tropical dermatology with a particular focus on skin cancer prevention for persons with albinism and noma prevention.

Programme delivery is conducted through partnerships rather than direct service provision: the foundation co-designs and co-finances initiatives with local NGOs such as Standing Voice, SIAM (Mali), and Vaincre noma, with academic institutions including Paris-Descartes, Toulouse, and Aix-Marseille universities, and with national health systems including CNAM Mali, Panzi Hospital in the DRC, and the Persis paediatric centre in Burkina Faso. Documented outcomes include a 71% reduction in skin cancers among 465 monitored patients in the Mwanza region, 67,000 people reached through theatrical noma-awareness performances, and 5,900+ persons with albinism supported in Tanzania plus 1,600 in Malawi.

The foundation's business model is grant-making and programme-funding rather than commercial: it does not sell products or services, generates no product revenue, and is funded through its endowment and donations. It does not operate as a technology product company; its underlying capability is international development programme design, multi-country partnership orchestration, and capacity-building (training, screening, awareness). Distribution of impact occurs via grant disbursement, co-financed field programmes, university-led curricula, and digital channels (website, social media, podcasts, the annual ODESS conference, and an Albinism Awareness Toolbox).

Name

Fondation Pierre Fabre

Legal name

Fondation Pierre Fabre

Website

https://fondationpierrefabre.org

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Fondation Pierre Fabre is a French public utility foundation that funds and operates 35 healthcare programmes across 22 countries in the Global South, focused on pharmaceutical training, sickle cell disease, healthcare access for vulnerable populations, e-health, and tropical dermatology.

Ownership category

akta.pro rank

Product category

Global Health Foundation Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Social Sciences and Humanities (541720), Professional, Scientific, and Technical Services (541)

SIC

Services-Misc Health & Allied Services, Nec (8090), International Affairs (9721), Services-Management Consulting Services (8742)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Monitoring, Evaluation, Research & Learning (MERL) for Global Health (BPADAIAO)

Keywords

• Global health programmes
• Pharmaceutical training
• Sickle cell disease
• Tropical dermatology
• E-health observatory

Headquarters

HQ city

Lavaur

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others, Marketing or Sales

Distribution channels3 records

Marketing channels7 records

Core offering

Fondation Pierre Fabre is a recognized public-utility foundation that designs, funds, and implements global health programmes in the Global South. Its activities span five flagship areas: training pharmaceutical professionals (drug quality, pharmacy practice), combating sickle cell disease (screening and patient care), improving access to healthcare for vulnerable populations (Noma prevention, skin cancer in persons with albinism), developing e-health (the ODESS observatory, teledermatology, digital training), and tropical dermatology (research, training, and care). It operates as a grant-maker and programme operator, funding partner organizations and delivering initiatives directly in Africa and South-East Asia.

Product overview

Fondation Pierre Fabre operates as a public interest foundation focused on improving access to healthcare and quality medications in developing countries. The organization delivers programs across five main areas: training of pharmaceutical professionals (including the Master Mekong Pharma), combating sickle cell disease, healthcare access for vulnerable populations, e-health initiatives (including the Global South E-Health Observatory), and tropical dermatology. The portfolio includes awareness toolboxes, prevention programs, teledermatology services, and educational resources. Currently operates 35 programs across 22 countries with a focus on sub-Saharan Africa and Southeast Asia.

Differentiator

Problem solved

Functional benefit

Products and services

• Formation des professionnels du médicament (Training of Pharmaceutical Professionals) A flagship programme that strengthens pharmaceutical capacity in the Global South by training pharmacists and drug-quality professionals through university partnerships, scholarships, and continuing professional development. Targeted at pharmacy faculties, regulators, and individual pharmacists in Africa and South-East Asia.

Quantifiable outcome

• 1,937 consultations realised for persons with albinism in Mali; 6,555 pots of sun-protection cream produced and distributed
• +5 more outcomes

Segments1 record

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

16 partnerships are on record, tiered core and minor.

• Standing VoicecoreStrategic or Co-development PartnerStanding Voice is an NGO founded in 2013 working for the promotion of social inclusion and the end of human rights violations against marginalised groups. In Tanzania and Malawi, the foundation supports Standing Voice's Skin Cancer Prevention programme, which organises regular 'clinics' for persons with albinism, providing dermatological consultations, sun-protection cream, and awareness sessions. The programme covers 27 clinics reaching 2,000 beneficiaries, with an observed 71% reduction in skin cancers among monitored patients.
• SIAM (Solidarité pour l'Insertion des Albinos au Mali)coreStrategic or Co-development PartnerSIAM is a Malian association working to improve the lives of persons with albinism. The foundation supports SIAM in training health agents, producing and distributing locally-made sun-protection cream, and providing dermatological consultations in six regions of Mali (Bamako, Sikasso, Kayes, Yélimané, Koulikoro, and Ségou). Since the programme started, 1,937 consultations have been realised and 6,555 pots of cream distributed.
• Vaincre nomacoreStrategic or Co-development PartnerVaincre noma is a French association dedicated to fighting noma, a gangrenous stomatitis affecting malnourished children. The foundation co-finances awareness campaigns and supports the medical-social follow-up of children affected by noma in Burkina Faso's Sahel region. 80 theatrical performances reached over 67,000 people, and 300 educational talks were organised in 2017.
• Réseau pour la Promotion de la Santé Bucco-Dentaire et la Recherche en AfriqueminorStrategic or Co-development PartnerPartners with Vaincre noma and the foundation in organising oral health and noma prevention campaigns in Burkina Faso.
• Centre National d'Appui à la lutte contre la Maladie (CNAM, Mali)coreStrategic or Co-development PartnerCNAM (formerly Institut Marchoux), the national dermatology reference centre in Mali, collaborates with the foundation and SIAM on albinism skin cancer prevention, providing dermatologists for consultations and training health agents in six regions.
• Centre médico-chirurgical pédiatrique Persis (Burkina Faso)coreStrategic or Co-development PartnerThe foundation supports the Persis centre, directed by Dr Zala, for the medical-social follow-up of children affected by noma in the Ouahigouya region of northern Burkina Faso.
• Fondation Panzi (DRC)coreStrategic or Co-development PartnerThe foundation reaffirmed its commitment alongside the Fondation Panzi, founded by Nobel laureate Dr Denis Mukwege, to support victims of sexual violence and populations in conflict zones in the DRC. The foundation supports specialised training in vaginal surgery at Panzi Hospital.
• Université Paris-Descartes (France)coreStrategic or Co-development PartnerPartner university in the Master Mekong Pharma programme, associated with Hanoi University of Pharmacy. Provides academic coordination and volunteer instructors for the two-year postgraduate pharmaceutical training programme in Southeast Asia.
• Université de Toulouse (France)coreStrategic or Co-development PartnerPartner university in the Master Mekong Pharma programme, associated with Vientiane University of Health Sciences in Laos. Contributes academic support and volunteer teaching staff.
• Université d'Aix-Marseille (France)coreStrategic or Co-development PartnerPartner university in the Master Mekong Pharma programme, associated with Phnom Penh University in Cambodia. Provides academic coordination for the two-year pharmaceutical sciences master's programme.
• Hanoi University of Pharmacy (Vietnam)coreStrategic or Co-development PartnerPartner institution in the Master Mekong Pharma programme. Hosted the first graduation ceremony in October 2014 for the inaugural class of the transnational master's programme spanning Vietnam, Cambodia, and Laos.
• Université des Sciences de la Santé du Laos (Laos)coreStrategic or Co-development PartnerLaos partner in the Master Mekong Pharma programme, hosting the second year of the master's. Welcomed its first cohort of students in October 2014.
• Université de Phnom Penh (Cambodge)coreStrategic or Co-development PartnerCambodian partner university in the Master Mekong Pharma programme, delivering the pharmaceutical sciences master's in collaboration with Aix-Marseille University.
• Agence universitaire de la Francophonie (AUF)minorStrategic or Co-development PartnerProvides institutional support for the Master Mekong Pharma programme, contributing to the international recognition and reach of the pharmaceutical training network.
• Coopération françaiseminorStrategic or Co-development PartnerSupports the Master Mekong Pharma programme as part of France's international cooperation in higher education and health capacity building in Southeast Asia.
• Africa Albinism Network (AAN)minorStrategic or Co-development PartnerAfrican network producing testimonials and stories of persons with albinism (Joselito from Brazil, Nnene from Nigeria, Simon from DRC) that are shared through the foundation's Albinism Awareness Toolbox.

Scale indicators2 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Fondation Panzi: DRC-based foundation founded by Nobel laureate Dr Denis Mukwege, providing holistic care to survivors of sexual violence — already a direct partner of Fondation Pierre Fabre, making it a natural comparable.
• Fondation Mérieux: French independent family foundation focused on improving access to diagnosis and healthcare for vulnerable populations in developing countries, with strong capacity-building and laboratory medicine programmes — closely aligned with Fondation Pierre Fabre's pharma training and access-to-care mandate.
• Drugs for Neglected Diseases initiative (DNDi): International not-for-profit R&D organisation that develops treatments for neglected diseases and partners across Global South research networks — a direct comparator in global health research and product development partnerships.

Broad incumbents

• Institut Pasteur: Internationally recognised French research foundation with a global network of Pasteur Institutes focused on infectious diseases and public health — comparable as a French-rooted health research and training institution working across the Global South.
• Clinton Health Access Initiative (CHAI): Global health organisation that works with governments to strengthen health systems and improve access to medicines — comparable on healthcare-access-for-vulnerable-populations and medicines-quality programmes.
• Agence Française de Développement (AFD): France's bilateral development finance institution funding health, education and social programmes in the Global South — relevant as a French institutional counterpart for co-funding the foundation's country programmes.
• Fondation de France: France's largest multi-purpose philanthropic foundation, active across health and development causes including international solidarity; broader portfolio but operates with the same public-utility foundation model and French donor ecosystem.
• Wellcome Trust: Large UK-based charitable foundation funding global health research, including infectious disease and mental health — relevant comparable for foundations funding research, training and access-to-medicines programmes at scale.
• PATH: Global non-profit focused on health equity and innovation across multiple disease areas, working with public and private partners in low- and middle-income countries — comparable portfolio breadth and Global South focus.
• Médecins Sans Frontières (MSF): Largest global medical-humanitarian NGO delivering frontline healthcare in fragile states — overlapping with Fondation Pierre Fabre on access-to-care for vulnerable populations and conflict-zone service delivery, though operating at far greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/FondationPFabre
• YouTubeyoutube.com/channel/UCSTB8YVIiEnbarvfFcQ-4UA
• Facebookfacebook.com/FondationPierreFabre
• LinkedInlinkedin.com/company/fondation_pierrefabre

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fondation Pierre Fabre